Absci Corporation Share Price & Technical Analysis
ABSI · $5.28 (-4.69%)
Healthcare / Biotechnology
$5.28
-4.69%
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the …
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
4% return in May, 6% avg return in past 3 year May month.
65% return in 2026, 69% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -14% | -7% | 15% | 67% | 4% | – | – | – | – | – | – | – | 65% |
| 25 | 37% | 9% | -36% | 24% | -13% | -4% | 8% | -14% | 30% | 43% | -26% | 13% | 72% |
| 24 | -2% | 30% | 10% | -18% | -14% | -28% | 42% | 0% | -14% | 0% | -23% | -16% | -33% |
| 23 | 41% | -34% | -14% | -28% | 46% | -21% | 47% | -18% | -28% | 0% | 31% | 147% | 168% |
| 22 | -18% | 32% | -10% | -31% | -37% | -11% | 0% | 3% | -6% | 0% | -22% | -19% | -119% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$843.45M
P/E ratio
—
52W high
$6.72
52W low
$2.24
Volume
3,20,854
Beta
2.38
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Absci Corporation share price today?
- Absci Corporation (ABSI) last traded around $5.28 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ABSI have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ABSI. Download the app for real-time alerts.
- How can I analyze Absci Corporation stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.